Just under five months after Novo Nordisk secured a US Food and Drug Administration (FDA) approval for sending the once-weekly growth hormone Sogroya on the market the European Medicines Agency (EMA) also announces their positive assessment of the treatment.
At the Committee for Medicinal Products for Human use meeting in January, the group of experts passed an EMA recommendation to issue a marketing authorization for the drug as a treatment for adults.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Nordic Medical Affairs Manager 
Biomarker Operations Lead 
Consultant Manager 
Project Manager & Scrum Master 
IRT Manager, Clinical Drug Supply 
Senior IT Network Engineer 
Client Talent Acquisition Specialist 
Director Global Engineering 
Director for innovative pre-clinical testing unit 
Key Account Manager, Europe and Asia 
Biostatistician 
Procurement Process Excellence Specialist 
Clinical Trial Manager